Theo M. de Reijke

Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911)

M. Bolla, Hendrik Van Poppel, Laurence Collette et al. · The Lancet · 2005 · 1.1K citations

Urology, Surgical Oncology, Radiation Medicine +9

Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)

M. Bolla, Hendrik Van Poppel, Bertrand Tombal et al. · The Lancet · 2012 · 856 citations

Radiation Medicine, Surgical Oncology, Urology +9

EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non–Muscle-invasive Stage Ta–T1 Urothelial Bladder Cancer Patients Treated with 1–3 Years of Maintenance Bacillus Calmette-Guérin

Samantha Cambier, Richard Sylvester, Laurence Collette et al. · European Urology · 2015 · 616 citations · Full text

Eortc Nomograms, Prognostic Biomarkers, Urology +10

Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder

Richard Sylvester, Maurizio Brausi, Wim J. Kirkels et al. · European Urology · 2009 · 426 citations · Full text

Urological Research, Urology, Bacillus Calmette-guérin +9

Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker–Based Risk Score

Leander Van Neste, Rianne J. Hendriks, Siebren Dijkstra et al. · European Urology · 2016 · 359 citations

Biomarker (Medicine), Prognostic Biomarkers, Urology +11